Healthcare & Life Sciences
Tendyne
United States
series-c-plus
series-c-plus
Stage
1
Investors
About
Tendyne develops transcatheter mitral valve replacement (TMVR) systems to treat mitral valve disease using minimally invasive, catheter-delivered heart valve implants.
Explore Tendyne's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.